fcgr3a polyclonal antibody (Proteintech)
Structured Review
Fcgr3a Polyclonal Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 95/100, based on 77 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fcgr3a+polyclonal+antibody/CD16+Antibody/10__1096_slash_fj__202500034rr-81-73-79
Average 95 stars, based on 77 article reviews
Images
Related Articles
Gene Expression:Article Title: Cellular Landscape of Synovial Chondromatosis Synovium Revealed by Single‐Cell RNA Sequencing Article Snippet: These sequential steps were performed to optimize the immunostaining process and facilitate accurate visualization of the target antigens.sequential steps were performed to optimize the immunostaining process and facilitate accurate visualization of the target antigens. ... The primary antibodies used included Collagen Type III (N- terminal) Polyclonal antibody (22734- 1- AP, Proteintech, 1:1000), MMP3 Polyclonal antibody (17873- 1- AP, Proteintech, 1:100), MMP1 Polyclonal antibody (10371- 2- AP, Proteintech, 1:100), S100A10 Polyclonal antibody (11250- 1- AP, Proteintech, 1:400), TIMD4 Polyclonal antibody (12008- 1- AP, Proteintech, 1:200), CNRIP1 Polyclonal antibody (16827- 1- AP, Proteintech, 1:200), C1QA Monoclonal antibody (67063- 1- IG, Proteintech, 1:100), CSF1R Polyclonal antibody (25949- 1- AP, Proteintech, 1:50), FCGR3A Polyclonal antibody ( Article Title: Cellular Landscape of Synovial Chondromatosis Synovium Revealed by Single‐Cell RNA Sequencing Article Snippet: These sequential steps were performed to optimize the immunostaining process and facilitate accurate visualization of the target antigens.These sequential steps were performed to optimize the immunostaining process and facilitate accurate visualization of the target antigens.. The primary antibodies used included Collagen Type III (N‐terminal) Polyclonal antibody (22734‐1‐AP, Proteintech, 1:1000), MMP3 Polyclonal antibody (17873‐1‐AP, Proteintech, 1:100), MMP1 Polyclonal antibody (10371‐2‐AP, Proteintech, 1:100), S100A10 Polyclonal antibody (11250‐1‐AP, Proteintech, 1:400), TIMD4 Polyclonal antibody (12008‐1‐AP, Proteintech, 1:200), CNRIP1 Polyclonal antibody (16827‐1‐AP, Proteintech, 1:200), C1QA Monoclonal antibody (67063‐1‐IG, Proteintech, 1:100), CSF1R Polyclonal antibody (25949‐1‐AP, Proteintech, 1:50), FCGR3A Polyclonal Expressing:Article Title: Cellular Landscape of Synovial Chondromatosis Synovium Revealed by Single‐Cell RNA Sequencing Article Snippet: These sequential steps were performed to optimize the immunostaining process and facilitate accurate visualization of the target antigens.sequential steps were performed to optimize the immunostaining process and facilitate accurate visualization of the target antigens. ... The primary antibodies used included Collagen Type III (N- terminal) Polyclonal antibody (22734- 1- AP, Proteintech, 1:1000), MMP3 Polyclonal antibody (17873- 1- AP, Proteintech, 1:100), MMP1 Polyclonal antibody (10371- 2- AP, Proteintech, 1:100), S100A10 Polyclonal antibody (11250- 1- AP, Proteintech, 1:400), TIMD4 Polyclonal antibody (12008- 1- AP, Proteintech, 1:200), CNRIP1 Polyclonal antibody (16827- 1- AP, Proteintech, 1:200), C1QA Monoclonal antibody (67063- 1- IG, Proteintech, 1:100), CSF1R Polyclonal antibody (25949- 1- AP, Proteintech, 1:50), FCGR3A Polyclonal antibody ( Article Title: Cellular Landscape of Synovial Chondromatosis Synovium Revealed by Single‐Cell RNA Sequencing Article Snippet: These sequential steps were performed to optimize the immunostaining process and facilitate accurate visualization of the target antigens.These sequential steps were performed to optimize the immunostaining process and facilitate accurate visualization of the target antigens.. The primary antibodies used included Collagen Type III (N‐terminal) Polyclonal antibody (22734‐1‐AP, Proteintech, 1:1000), MMP3 Polyclonal antibody (17873‐1‐AP, Proteintech, 1:100), MMP1 Polyclonal antibody (10371‐2‐AP, Proteintech, 1:100), S100A10 Polyclonal antibody (11250‐1‐AP, Proteintech, 1:400), TIMD4 Polyclonal antibody (12008‐1‐AP, Proteintech, 1:200), CNRIP1 Polyclonal antibody (16827‐1‐AP, Proteintech, 1:200), C1QA Monoclonal antibody (67063‐1‐IG, Proteintech, 1:100), CSF1R Polyclonal antibody (25949‐1‐AP, Proteintech, 1:50), FCGR3A Polyclonal Marker:Article Title: Cellular Landscape of Synovial Chondromatosis Synovium Revealed by Single‐Cell RNA Sequencing Article Snippet: These sequential steps were performed to optimize the immunostaining process and facilitate accurate visualization of the target antigens.sequential steps were performed to optimize the immunostaining process and facilitate accurate visualization of the target antigens. ... The primary antibodies used included Collagen Type III (N- terminal) Polyclonal antibody (22734- 1- AP, Proteintech, 1:1000), MMP3 Polyclonal antibody (17873- 1- AP, Proteintech, 1:100), MMP1 Polyclonal antibody (10371- 2- AP, Proteintech, 1:100), S100A10 Polyclonal antibody (11250- 1- AP, Proteintech, 1:400), TIMD4 Polyclonal antibody (12008- 1- AP, Proteintech, 1:200), CNRIP1 Polyclonal antibody (16827- 1- AP, Proteintech, 1:200), C1QA Monoclonal antibody (67063- 1- IG, Proteintech, 1:100), CSF1R Polyclonal antibody (25949- 1- AP, Proteintech, 1:50), FCGR3A Polyclonal antibody ( Article Title: Cellular Landscape of Synovial Chondromatosis Synovium Revealed by Single‐Cell RNA Sequencing Article Snippet: These sequential steps were performed to optimize the immunostaining process and facilitate accurate visualization of the target antigens.These sequential steps were performed to optimize the immunostaining process and facilitate accurate visualization of the target antigens.. The primary antibodies used included Collagen Type III (N‐terminal) Polyclonal antibody (22734‐1‐AP, Proteintech, 1:1000), MMP3 Polyclonal antibody (17873‐1‐AP, Proteintech, 1:100), MMP1 Polyclonal antibody (10371‐2‐AP, Proteintech, 1:100), S100A10 Polyclonal antibody (11250‐1‐AP, Proteintech, 1:400), TIMD4 Polyclonal antibody (12008‐1‐AP, Proteintech, 1:200), CNRIP1 Polyclonal antibody (16827‐1‐AP, Proteintech, 1:200), C1QA Monoclonal antibody (67063‐1‐IG, Proteintech, 1:100), CSF1R Polyclonal antibody (25949‐1‐AP, Proteintech, 1:50), FCGR3A Polyclonal Control:Article Title: Cellular Landscape of Synovial Chondromatosis Synovium Revealed by Single‐Cell RNA Sequencing Article Snippet: These sequential steps were performed to optimize the immunostaining process and facilitate accurate visualization of the target antigens.sequential steps were performed to optimize the immunostaining process and facilitate accurate visualization of the target antigens. ... The primary antibodies used included Collagen Type III (N- terminal) Polyclonal antibody (22734- 1- AP, Proteintech, 1:1000), MMP3 Polyclonal antibody (17873- 1- AP, Proteintech, 1:100), MMP1 Polyclonal antibody (10371- 2- AP, Proteintech, 1:100), S100A10 Polyclonal antibody (11250- 1- AP, Proteintech, 1:400), TIMD4 Polyclonal antibody (12008- 1- AP, Proteintech, 1:200), CNRIP1 Polyclonal antibody (16827- 1- AP, Proteintech, 1:200), C1QA Monoclonal antibody (67063- 1- IG, Proteintech, 1:100), CSF1R Polyclonal antibody (25949- 1- AP, Proteintech, 1:50), FCGR3A Polyclonal antibody ( Article Title: Cellular Landscape of Synovial Chondromatosis Synovium Revealed by Single‐Cell RNA Sequencing Article Snippet: These sequential steps were performed to optimize the immunostaining process and facilitate accurate visualization of the target antigens.These sequential steps were performed to optimize the immunostaining process and facilitate accurate visualization of the target antigens.. The primary antibodies used included Collagen Type III (N‐terminal) Polyclonal antibody (22734‐1‐AP, Proteintech, 1:1000), MMP3 Polyclonal antibody (17873‐1‐AP, Proteintech, 1:100), MMP1 Polyclonal antibody (10371‐2‐AP, Proteintech, 1:100), S100A10 Polyclonal antibody (11250‐1‐AP, Proteintech, 1:400), TIMD4 Polyclonal antibody (12008‐1‐AP, Proteintech, 1:200), CNRIP1 Polyclonal antibody (16827‐1‐AP, Proteintech, 1:200), C1QA Monoclonal antibody (67063‐1‐IG, Proteintech, 1:100), CSF1R Polyclonal antibody (25949‐1‐AP, Proteintech, 1:50), FCGR3A Polyclonal Immunohistochemistry:Article Title: Cellular Landscape of Synovial Chondromatosis Synovium Revealed by Single‐Cell RNA Sequencing Article Snippet: These sequential steps were performed to optimize the immunostaining process and facilitate accurate visualization of the target antigens.sequential steps were performed to optimize the immunostaining process and facilitate accurate visualization of the target antigens. ... The primary antibodies used included Collagen Type III (N- terminal) Polyclonal antibody (22734- 1- AP, Proteintech, 1:1000), MMP3 Polyclonal antibody (17873- 1- AP, Proteintech, 1:100), MMP1 Polyclonal antibody (10371- 2- AP, Proteintech, 1:100), S100A10 Polyclonal antibody (11250- 1- AP, Proteintech, 1:400), TIMD4 Polyclonal antibody (12008- 1- AP, Proteintech, 1:200), CNRIP1 Polyclonal antibody (16827- 1- AP, Proteintech, 1:200), C1QA Monoclonal antibody (67063- 1- IG, Proteintech, 1:100), CSF1R Polyclonal antibody (25949- 1- AP, Proteintech, 1:50), FCGR3A Polyclonal antibody ( Article Title: Cellular Landscape of Synovial Chondromatosis Synovium Revealed by Single‐Cell RNA Sequencing Article Snippet: These sequential steps were performed to optimize the immunostaining process and facilitate accurate visualization of the target antigens.These sequential steps were performed to optimize the immunostaining process and facilitate accurate visualization of the target antigens.. The primary antibodies used included Collagen Type III (N‐terminal) Polyclonal antibody (22734‐1‐AP, Proteintech, 1:1000), MMP3 Polyclonal antibody (17873‐1‐AP, Proteintech, 1:100), MMP1 Polyclonal antibody (10371‐2‐AP, Proteintech, 1:100), S100A10 Polyclonal antibody (11250‐1‐AP, Proteintech, 1:400), TIMD4 Polyclonal antibody (12008‐1‐AP, Proteintech, 1:200), CNRIP1 Polyclonal antibody (16827‐1‐AP, Proteintech, 1:200), C1QA Monoclonal antibody (67063‐1‐IG, Proteintech, 1:100), CSF1R Polyclonal antibody (25949‐1‐AP, Proteintech, 1:50), FCGR3A Polyclonal |
